BIOMAT Database Logo BIOMAT Database Logo

Current status of the biology and treatment of acute non-lymphocytic leukemia in children (report from the ANLL strategy group of the Children's Cancer Study Group. 1983

B C Lampkin, and W Woods, and R Strauss, and S Feig, and G Higgins, and I Bernstein, and G D'Angio, and R Chard, and A Bleyer, and D Hammond

Major advances have been made in the past 10 yr in both the understanding of the biologic characteristics of acute nonlymphocytic leukemia and in the treatment of patients with this disease. Advances in the biologic characteristics include: a better understanding of the nature of leukemic cell proliferation and differentiation; a clearer description of the morphological, histochemical, and ultrastructural characteristics of leukemic cells; a recognition that a high percentage of patients may have specific cytogenetic abnormalities; and a recognition that biochemical differences exist between acute nonlymphocytic leukemia (ANLL) and acute lymphoblastic leukemia (ALL). Today, over 70% of children with ANLL can be induced into a complete remission and over 25% are remaining in a continuous remission for over 2 yr. In spite of these improved results, the best method of extending remissions is unknown. It is unlikely that better results of therapy will be achieved in the future by tailoring the treatment according to the biologic characteristics of the patient, since it appears that ANLL is a heterogeneous group of diseases.

UI MeSH Term Description Entries
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008938 Mitosis A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species. M Phase, Mitotic,Mitotic M Phase,M Phases, Mitotic,Mitoses,Mitotic M Phases,Phase, Mitotic M,Phases, Mitotic M
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses

Related Publications

B C Lampkin, and W Woods, and R Strauss, and S Feig, and G Higgins, and I Bernstein, and G D'Angio, and R Chard, and A Bleyer, and D Hammond
[Treatment of acute nonlymphoblastic leukemia in childhood: results of protocol ANLL-827 and ANLL-861 studies. Children's Cancer and Leukemia Study Group].
October 1987, [Rinsho ketsueki] The Japanese journal of clinical hematology,
B C Lampkin, and W Woods, and R Strauss, and S Feig, and G Higgins, and I Bernstein, and G D'Angio, and R Chard, and A Bleyer, and D Hammond
Improved prognosis of acute nonlymphocytic leukemia in children: results of the 12th-ANLL protocol of Tokyo Children's Cancer Study Group.
August 1991, Acta paediatrica Japonica : Overseas edition,
B C Lampkin, and W Woods, and R Strauss, and S Feig, and G Higgins, and I Bernstein, and G D'Angio, and R Chard, and A Bleyer, and D Hammond
[Current status of the treatment of acute non-lymphocytic leukemia in adults].
May 1989, Zhonghua nei ke za zhi,
B C Lampkin, and W Woods, and R Strauss, and S Feig, and G Higgins, and I Bernstein, and G D'Angio, and R Chard, and A Bleyer, and D Hammond
Acute non-lymphocytic leukemia (ANLL) following treatment with dacarbazine for malignant melanoma.
May 1987, American journal of hematology,
B C Lampkin, and W Woods, and R Strauss, and S Feig, and G Higgins, and I Bernstein, and G D'Angio, and R Chard, and A Bleyer, and D Hammond
Current neurosurgical treatment of medulloblastomas in children. A report from the Children's Cancer Study Group.
January 1989, Pediatric neuroscience,
B C Lampkin, and W Woods, and R Strauss, and S Feig, and G Higgins, and I Bernstein, and G D'Angio, and R Chard, and A Bleyer, and D Hammond
Biology and treatment of acute lymphocytic leukemia in children.
February 1997, Seminars in oncology,
B C Lampkin, and W Woods, and R Strauss, and S Feig, and G Higgins, and I Bernstein, and G D'Angio, and R Chard, and A Bleyer, and D Hammond
Chromosomes and causation of human cancer and leukemia. XXXV. The missing Y in acute non-lymphocytic leukemia (ANLL).
January 1980, Cancer,
B C Lampkin, and W Woods, and R Strauss, and S Feig, and G Higgins, and I Bernstein, and G D'Angio, and R Chard, and A Bleyer, and D Hammond
[Surface marker analysis with monoclonal antibodies in acute non-lymphocytic leukemia in childhood. Children's Cancer and Leukemia Study group].
May 1985, [Rinsho ketsueki] The Japanese journal of clinical hematology,
B C Lampkin, and W Woods, and R Strauss, and S Feig, and G Higgins, and I Bernstein, and G D'Angio, and R Chard, and A Bleyer, and D Hammond
[Immunotherapy with bestatin for acute non-lymphocytic leukemia (ANLL) in adults].
December 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
B C Lampkin, and W Woods, and R Strauss, and S Feig, and G Higgins, and I Bernstein, and G D'Angio, and R Chard, and A Bleyer, and D Hammond
Improved treatment results of non-Hodgkin's lymphoma in children: a report from the Children's Cancer and Leukemia Study Group of Japan.
February 1995, International journal of hematology,
Copied contents to your clipboard!